Alanta Health Group

What Alanta Health Group does

Alanta Health Group is a privately held German healthcare holding (alanta health group GmbH, HRB 140278 Amtsgericht Hamburg), founded in 2017 and headquartered in Hamburg, that operates five integrated business divisions covering the medical-pharmaceutical value chain in Germany. Through its subsidiaries ZytoService Deutschland GmbH, alanta med GmbH, VIVATIS Arzneimittel GmbH and SKH Stadtteilklinik Hamburg plus a nationwide network of specialized MVZ entities, the group produces patient-individual parenteral cytostatic infusion solutions in four EU-GMP-certified cleanroom facilities (Hamburg, Leipzig, Haan/Düsseldorf, plus a planned Freising site), distributes pharmaceutical products through a GDP-certified wholesale arm handling more than 50,000 shipments and 2.5 million packages per year, and delivers inpatient and outpatient specialist care in oncology, hematology, gynecology, gastroenterology and immunology across more than a dozen German cities.

The group's core technology stack combines pharmaceutical manufacturing at the highest cleanroom class under §13 AMG with the proprietary oncotrace oncology therapy management software, which provides planning, ordering, administration and documentation modules with native AIS practice-system interfaces, Onkologievereinbarung-compliant tumor documentation, cancer registry reporting, scheduling and statistics. Production is pharmacist-supervised, with more than 60 licensed pharmacists on staff and an in-house ZytoService Akademie delivering accredited GMP/GCP training. Infrastructure also includes a rexx-systems-powered applicant management portal, external data hosting under §28 DSGVO, and B2B healthcare logistics capabilities (temperature-controlled storage, batch/expiry/serial number management, returns and complaint handling).

Commercially, the group runs a B2B direct-sales motion with multiple revenue streams: contract manufacturing of cytostatic infusions per individual physician prescription (with next-day nationwide delivery, 365 days/year), pharmaceutical wholesale under §52a AMG, full-service healthcare logistics to outside pharma and medtech customers, software licensing of oncotrace to oncology practices, and clinical-study support (including preparation of study medications and Phase III administrative services). Pricing is quote-based and not publicly disclosed, compensation is market/function/performance-oriented, and customer reach spans pharmacies, hospitals, ambulatory clinics and physician practices across Germany, with patient-facing care delivered through the SKH hospital and the MVZ network.

Name

Alanta Health Group

Legal name

alanta health group Gesellschaft mit beschränkter Haftung

Website

https://alanta-group.de

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Alanta Health Group is a privately held Hamburg-based German healthcare holding that, through ZytoService, alanta med and VIVATIS, produces patient-individual cytostatic infusions in four EU-GMP cleanroom sites, distributes specialty pharmaceuticals, runs a nationwide MVZ and hospital network, and licenses the oncotrace oncology therapy software to oncology practices in Germany.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Manufacturing & Healthcare Services

NAICS

Offices of Physicians (62111), General Medical and Surgical Hospitals (622110), Ambulatory Health Care Services (621)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

akta.pro secondary industries

Hospital-Owned Physician Networks & Medical Groups (HLAFAAAL), Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)

Keywords

• Patient-individual infusions
• Pharmaceutical contract manufacturing
• Oncology infusion solutions
• Pharmaceutical wholesale distribution
• Specialist medical care centers

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices19 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Pharmaceutical manufacturing (contract manufacturing): ZytoService Deutschland GmbH produces patient-individual parenteral infusion solutions (cytostatics) under §13 AMG manufacturing license on behalf of pharmacies per individual physician prescription. Production at four sites (Hamburg, Leipzig, Düsseldorf/Haan, Munich) with nationwide next-day delivery. Up to 2,500 infusion solutions daily, 365 days/year.
2. Pharmaceutical wholesale: VIVATIS Arzneimittel GmbH operates as pharmaceutical wholesaler under § 52a AMG wholesale license, supplying highly specialized pharmacies. Strategic procurement and supply in oncology, autoimmunology, rheumatology and multiple sclerosis. Operates 24 VIVATIS-locations in Hamburg. More than 50,000 product shipments and 2.5 million packages per year.
3. Healthcare logistics services: VIVATIS HealthCare Logistik provides full-service warehouse and logistics services for healthcare and pharma customers (startups and mid-sized companies). Includes temperature-controlled storage per GDP ('Good Distribution Practice'), batch/expiry/serial number management, order processing, customer service, national and international shipping, invoicing, returns and complaint management.
4. Patient care services (inpatient and outpatient): alanta med GmbH operates the SKH Stadtteilklinik Hamburg hospital (Innere Medizin, Chirurgie/Orthopädie, Gynäkologie, HNO) and a network of Medizinische Versorgungszentren (MVZ) across Germany providing ambulatory specialist care in hematology/oncology, gynecology/gynecological oncology, gastroenterology and immunology. Also operates Psychiatrische Tagesklinik at Praxisklinik Mümmelmannsberg.
5. Medical software licensing (oncotrace): oncotrace oncology therapy planning, ordering, administration and documentation software sold to oncology practices. Modular architecture allows individualized packages; integrates with AIS practice systems.
6. Clinical research support: Manufacturing, storage and patient-individual preparation of study medications by ZytoService; administrative support for clinical studies in the MVZ network (including coding, documentation and data management for Phase III studies).

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

Alanta Health Group is a German healthcare holding that produces patient-individual parenteral cytostatic infusion solutions under EU-GMP at four cleanroom manufacturing sites (mainly for oncology), operates a national network of inpatient hospital and outpatient MVZ specialist care, runs pharmaceutical wholesale and GDP-compliant healthcare logistics, and licenses its proprietary oncotrace oncology therapy management software to oncology practices. The group integrates pharmaceutical contract manufacturing, distribution, logistics, clinical care and software along the medical-pharmaceutical value chain for the German market.

Differentiator

Problem solved

Functional benefit

Brands

• ZytoService: Pharmaceutical brand for the production of patient-specific parenteral infusion solutions (oncology) under EU-GMP at sites in Hamburg, Leipzig, Munich and Haan.
• alanta med
• VIVATIS
• oncotrace
• ZytoService Akademie
• SKH Stadtteilklinik Hamburg

Products and services

• Patient-individual cytostatic infusion manufacturing Contract manufacturing of patient-individual parenteral infusion solutions (cytostatics) for pharmacies and hospitals under §13 AMG manufacturing license. Production takes place in EU-GMP certified cleanroom laboratories of the highest cleanroom class, supervised by licensed pharmacists, 365 days per year, with next-day nationwide delivery across Germany. Designed for specialized pharmacies and clinical institutions serving oncology patients.
• Pharmaceutical wholesale (VIVATIS Arzneimittel) Distribution of highly specialized pharmaceuticals to pharmacies under §52a AMG wholesale dealer license, with strategic procurement and supply focus on oncology, autoimmunology, rheumatology and multiple sclerosis. Operates 24 VIVATIS locations in Hamburg with more than 50,000 product shipments and 2.5 million packages per year.
• Healthcare logistics services (VIVATIS HealthCare Logistik) Full-service warehouse and logistics services for healthcare and pharma customers, including temperature-controlled storage per GDP, batch/expiry/serial number management, order processing, customer service, national and international shipping, invoicing, returns and complaint management. Targeted at healthcare and pharma startups and mid-sized companies without their own GDP infrastructure.
• Inpatient hospital care (SKH Stadtteilklinik Hamburg) Inpatient hospital services at SKH Stadtteilklinik Hamburg in Hamburg-Mümmelmannsberg covering internal medicine, surgery/orthopaedics, gynaecology and ENT, with an affiliated Psychiatrische Tagesklinik at Praxisklinik Mümmelmannsberg. Operated by alanta med GmbH for individual patients in Germany.
• Outpatient specialist care (MVZ network) Ambulatory specialist medical care delivered through a nationwide network of Medizinische Versorgungszentren (MVZs) operated by alanta med GmbH, covering hematology/oncology, gynecology/gynecological oncology, gastroenterology and immunology across many German cities. Targeted at individual patients referred by primary or secondary care.
• oncotrace oncology therapy management software Proprietary oncology practice software that organizes planning, ordering, administration and documentation of oncological therapies for oncology practices and MVZs. Features a modular architecture allowing individual configuration, interfaces to AIS practice systems to avoid duplicate data entry, supports tumor documentation, cancer registry reporting, appointment planning and statistics, and is compliant with German data protection regulations. Licensed directly to oncology practices.
• Clinical research support services Clinical research support services including manufacturing, storage and patient-individual preparation of study medications by ZytoService, plus administrative support for clinical studies in the alanta med MVZ network (coding, documentation and data management for Phase III studies). Targeted at pharmaceutical sponsors and CROs running oncology and specialty therapy studies in Germany.

Quantifiable outcome

• Up to 2,500 infusion solutions produced daily across 4 manufacturing sites
• +4 more outcomes

Named customers2 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Six partnerships are on record, tiered flagship / core, core and minor.

• GHD GesundHeits GmbH Deutschland (Profusio-Gruppe)flagship / coreStrategic or Co-development Partner · 1 January 2018ZytoService Deutschland GmbH acquired the manufacturing capacities for patient-individual cytostatics in Haan, Munich and Leipzig from GHD's Profusio group in January 2018 (subject to antitrust approval, granted spring 2018). Production sites renamed under ZytoService Deutschland GmbH as of 1 September 2018. Under the agreement both companies cooperate intensively and use their combined GMP-compliant manufacturing expertise to ensure nationwide regional supply of cytostatics.
• antares-apotheken oHGcoreChannel Partner/ Reseller/ DistributorCooperation pharmacy partner for pharmaceutical student practical year (Praktisches Jahr) at ZytoService Deutschland GmbH. Allows pharmacy students to complete the offizin (community pharmacy) part of their PJ internship at one of antares' two main pharmacies. antares-pharma.de.
• Bundesverband der Betreiber medizinischer Versorgungszentren e.V. (BBMV)minorGTM or Marketing PartnerTrade association membership of alanta health group. The BBMV (bbmv.de) represents operators of Medizinische Versorgungszentren (MVZ) in Germany.
• Bundesverband der Rezeptur Herstellbetriebe e.V. (BRH)minorGTM or Marketing PartnerTrade association membership of alanta health group. The BRH (bundesverbandrezepturhersteller.de) represents manufacturers of pharmaceutical formulations/compounding in Germany.
• HansefitminorOthersCorporate fitness partnership allowing alanta employees flexible access to numerous fitness studios, swimming pools and other partners under the Hansefit program.
• Pluxee Benefits (Pluxee Benefits Pass / Pluxee Benefits Card)Others

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Helios / Fresenius Helios: Germany's largest private hospital chain and part of Fresenius; comparable to Alanta in operating a nationwide inpatient network and increasingly outpatient/MVZ services in oncology-adjacent specialties.
• Sanacorp Pharmahandel GmbH: German pharmaceutical wholesaler and pharmacy cooperative serving community pharmacies — overlaps with VIVATIS Arzneimittel's pharmaceutical wholesale and pharmacy-supply business under §52a AMG.
• Ameos Group: German-speaking private hospital and MVZ operator with a significant footprint in outpatient specialist care centers — directly comparable to alanta med's MVZ network across multiple German cities.
• CompuGroup Medical: Leading European provider of medical practice information systems (AIS/Praxissoftware) used by physicians in Germany; comparable to the AIS integration layer that underpins oncotrace's interoperability.
• Phoenix Group: Pan-European pharmaceutical wholesale, distribution and retail pharmacy group headquartered in Mannheim; competes with VIVATIS in German pharma wholesale and offers comparable specialty-pharmacy distribution services.
• Asklepios Kliniken: One of Germany's largest private hospital operators; comparable in operating hospital facilities (similar to SKH Stadtteilklinik Hamburg) and in running integrated care networks across multiple regions.
• Noweda eG: Germany's largest pharmacy cooperative wholesaler; comparable to VIVATIS in pharmaceutical wholesale and logistics to highly specialized pharmacies, with similar GDP-compliant distribution infrastructure.

Emerging players

• medondo AG: Specialty practice management software vendor for oncology, dermatology and other high-complexity specialties in Germany — an emerging competitor to oncotrace in oncology practice software.

Direct peers

• Medios AG: Berlin-based specialty pharma compounder focused on patient-individualized therapies including cytostatics, ophthalmology and other sterile infusions in Germany — the closest publicly traded direct competitor to ZytoService's compounding business.
• GHD GesundHeits GmbH Deutschland (Profusio-Gruppe): Former owner of the Profusio cytostatic manufacturing sites in Haan, Leipzig and Munich, which were divested to Alanta/ZytoService in 2018. Remains a competing compounder of patient-individual cytostatics in Germany and historically Alanta's most direct peer in this niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/alanta-health-group-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alanta Health Group